Utility of QuantiFERON-TB Gold In-Tube Test in the Diagnosis of Latent TB in HIV-Positive Patients in a Medium-TB Burden Country
Author(s) -
Hamideh Khazraiyan,
Zahra Abdi Liaei,
Hamid Emadi Koochak,
Farid Azmoudeh Ardalan,
Zahra Ahmadinejad,
Ahmad Soltani
Publication year - 2015
Publication title -
journal of the international association of providers of aids care (jiapac)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.813
H-Index - 31
eISSN - 2325-9582
pISSN - 2325-9574
DOI - 10.1177/2325957415614645
Subject(s) - medicine , concordance , quantiferon , latent tuberculosis , tuberculosis , human immunodeficiency virus (hiv) , gold standard (test) , history of tuberculosis , coinfection , mycobacterium tuberculosis , immunology , disease , pathology
Background: The authors aimed to compare TST with QuantiFERON-TB Gold In-Tube (QFT) for detecting latent tuberculosis infection (LTBI) in HIV-infected patients in Iran as a TB-medium endemic country.Methods: In a cross-sectional design,130 HIV-positive patients in HIV clinic of Tehran University were studied. Patients screened for LTBI with QFT and TST simultaneously. Concordance between 2 tests results and variables associated with tests discordance were assessed.Results: Positive results found in 24.6% for TST and 7.7% for QFT. Overall agreement between them was 73.85% (Kappa = 0.083). History of imprisonment was associated with more positive TST ( P = 0.014) and QFT ( P = 0.01). Patients with intravenous drug use (IDU) history had significant discordant results (0.018).Conclusion: The authors recommend QFT for all negative cases of TST in HIV-positive patients especially who had history of IDU.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom